NO20030812L - Bifenylderivater og anvendelse derav som integrininhibitorer - Google Patents
Bifenylderivater og anvendelse derav som integrininhibitorerInfo
- Publication number
- NO20030812L NO20030812L NO20030812A NO20030812A NO20030812L NO 20030812 L NO20030812 L NO 20030812L NO 20030812 A NO20030812 A NO 20030812A NO 20030812 A NO20030812 A NO 20030812A NO 20030812 L NO20030812 L NO 20030812L
- Authority
- NO
- Norway
- Prior art keywords
- biphenyl derivatives
- integrin inhibitors
- integrin
- inhibitors
- biphenyl
- Prior art date
Links
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 102000006495 integrins Human genes 0.000 title 1
- 108010044426 integrins Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10041428A DE10041428A1 (de) | 2000-08-23 | 2000-08-23 | Biphenylderivate |
| PCT/EP2001/008514 WO2002016323A1 (de) | 2000-08-23 | 2001-07-24 | Biphenylderivate und ihre verwendung als intigrininhibitoren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030812D0 NO20030812D0 (no) | 2003-02-21 |
| NO20030812L true NO20030812L (no) | 2003-02-21 |
Family
ID=7653542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030812A NO20030812L (no) | 2000-08-23 | 2003-02-21 | Bifenylderivater og anvendelse derav som integrininhibitorer |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20030187289A1 (no) |
| EP (1) | EP1311484A1 (no) |
| JP (1) | JP2004506717A (no) |
| KR (1) | KR20030022419A (no) |
| CN (1) | CN1447795A (no) |
| AU (1) | AU8973201A (no) |
| BR (1) | BR0113373A (no) |
| CA (1) | CA2420205A1 (no) |
| CZ (1) | CZ2003670A3 (no) |
| DE (1) | DE10041428A1 (no) |
| HU (1) | HUP0302822A3 (no) |
| MX (1) | MXPA03001556A (no) |
| NO (1) | NO20030812L (no) |
| PL (1) | PL359154A1 (no) |
| SK (1) | SK2952003A3 (no) |
| WO (1) | WO2002016323A1 (no) |
| ZA (1) | ZA200302253B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10127041A1 (de) * | 2001-06-02 | 2002-12-05 | Merck Patent Gmbh | Integrinantagonisten |
| WO2018046610A1 (en) | 2016-09-08 | 2018-03-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for diagnosing and treating nephrotic syndrome |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2221227T3 (es) * | 1997-11-24 | 2004-12-16 | MERCK & CO., INC. | Derivados sustituidos de beta-alanina como inhibidores de la adhesion celular. |
| WO1999052879A1 (en) * | 1998-04-14 | 1999-10-21 | American Home Products Corporation | Acylresorcinol derivatives as selective vitronectin receptor inhibitors |
| EP0960882A1 (en) * | 1998-05-19 | 1999-12-01 | Hoechst Marion Roussel Deutschland GmbH | Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
-
2000
- 2000-08-23 DE DE10041428A patent/DE10041428A1/de not_active Withdrawn
-
2001
- 2001-07-24 EP EP01969486A patent/EP1311484A1/de not_active Withdrawn
- 2001-07-24 MX MXPA03001556A patent/MXPA03001556A/es unknown
- 2001-07-24 CA CA002420205A patent/CA2420205A1/en not_active Abandoned
- 2001-07-24 JP JP2002521199A patent/JP2004506717A/ja active Pending
- 2001-07-24 CZ CZ2003670A patent/CZ2003670A3/cs unknown
- 2001-07-24 PL PL01359154A patent/PL359154A1/xx unknown
- 2001-07-24 HU HU0302822A patent/HUP0302822A3/hu unknown
- 2001-07-24 SK SK295-2003A patent/SK2952003A3/sk unknown
- 2001-07-24 CN CN01814415A patent/CN1447795A/zh active Pending
- 2001-07-24 KR KR10-2003-7002578A patent/KR20030022419A/ko not_active Withdrawn
- 2001-07-24 WO PCT/EP2001/008514 patent/WO2002016323A1/de not_active Ceased
- 2001-07-24 US US10/362,235 patent/US20030187289A1/en not_active Abandoned
- 2001-07-24 BR BR0113373-0A patent/BR0113373A/pt not_active Application Discontinuation
- 2001-08-23 AU AU8973201A patent/AU8973201A/xx active Pending
-
2003
- 2003-02-21 NO NO20030812A patent/NO20030812L/no unknown
- 2003-03-20 ZA ZA200302253A patent/ZA200302253B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE10041428A1 (de) | 2002-03-07 |
| US20030187289A1 (en) | 2003-10-02 |
| KR20030022419A (ko) | 2003-03-15 |
| MXPA03001556A (es) | 2003-06-06 |
| AU8973201A (en) | 2002-03-04 |
| SK2952003A3 (en) | 2003-06-03 |
| WO2002016323A1 (de) | 2002-02-28 |
| CN1447795A (zh) | 2003-10-08 |
| CZ2003670A3 (cs) | 2003-06-18 |
| NO20030812D0 (no) | 2003-02-21 |
| BR0113373A (pt) | 2003-07-15 |
| CA2420205A1 (en) | 2003-02-21 |
| ZA200302253B (en) | 2004-06-28 |
| HUP0302822A3 (en) | 2004-07-28 |
| EP1311484A1 (de) | 2003-05-21 |
| HUP0302822A2 (hu) | 2003-12-29 |
| PL359154A1 (en) | 2004-08-23 |
| JP2004506717A (ja) | 2004-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS6934A (is) | Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar | |
| NO20026010L (no) | Substituerte quinazolinderivater og deres anvendelse som inhibitorer | |
| DK1282611T3 (da) | Substituerede phenylacetatamider og anvendelse deraf som glucokinaseaktivatorer | |
| DK1246802T3 (da) | 4-aminopicolinater og deres anvendelse som herbicider | |
| DK1133477T3 (da) | Substituerede benzimidazoler og deres anvendelse som parpinhibitorer | |
| NO20030867L (no) | Hydroksamderivater anvendelig som deacetylaseinhibitorer | |
| DK2305250T3 (da) | Benzimidazolderivater og anvendelse heraf som proteinkinaseinhibitorer | |
| NO20012688D0 (no) | Benzamidderivater og anvendelse derav som APOB-100 sekresjonsinhibitorer | |
| NO20053356D0 (no) | Aminindazolderivater og anvendelse derav som kinaseinhibitorer. | |
| NO20032830D0 (no) | Tetrahydropyridinderivater, fremstilling derav og anvendelse som celle-proliferasjonsinhibitorer | |
| NO20025357L (no) | Antranylamider og deres anvendelse som legemidler | |
| DK1170288T3 (da) | Diphenylurinstofderivater og deres anvendelse som alfa2/5-HT2c-antagonister | |
| NO20042719L (no) | Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer | |
| NO20025150D0 (no) | 2-acylindolderivater og deres anvendelse som antitumormidler | |
| NO20025504D0 (no) | Nye tiokromanderivater og anvendelse derav som trombininhibitorer | |
| NO20030813D0 (no) | Bifenylderivater og deres anvendelse som integrininhibitorer | |
| DK1343764T3 (da) | Urinstof og urethanderivater som integrininhibitorer | |
| NO20030243L (no) | Nye forbindelser og deres anvendelse som glysintransportinhibitorer | |
| NO20030998L (no) | Arylpiperazinderivater og deres anvendelse som psykotropiske midler | |
| NO20023951D0 (no) | Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler | |
| NO20025884D0 (no) | 2-aminotiazolinderivater og deres anvendelse som NO- syntaseinhibitorer | |
| NO20030812L (no) | Bifenylderivater og anvendelse derav som integrininhibitorer | |
| NO20020592D0 (no) | Fluorenderivater som integrininhibitorer | |
| NO20025885D0 (no) | 4,5-dihydro-tiazol-2-ylaminderivater og deres anvendelse som NO-syntaseinhibitorer | |
| DK1202969T3 (da) | Biphenylderivater, deres fremstilling og deres anvendelse som MTP-inhibitor |